Our group and others have shown that aspirin, a stronger COX-1 than COX-2 inhibitor, and SC-560, a potent COX-1 selective inhibitor [57], suppress tumor growth in COX-1-overexpressing cell culture and mouse models of ovarian cancer [10–12, 14–17]. Here, PTGS2 is linked to ovarian carcinoma.